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ABSTRACT 
 
The transcription factor nuclear factor erythroid 
2-related factor 2 (Nrf2) regulates the 
expression of genes involved in antioxidant 
defenses to modulate fundamental cellular 
processes such as mitochondrial function and 
glutathione metabolism. Previous reports 
proposed that mitochondrial ROS production 
and disruption of the glutathione pool activate 
the Nrf2 pathway, suggesting that Nrf2 senses 
mitochondrial redox signals and/or oxidative 
damage and signals to the nucleus to respond 
appropriately. However, until now it has not 
been possible to disentangle the overlapping 
effects of mitochondrial superoxide/ hydrogen 
peroxide production as a redox signal from 
changes to mitochondrial thiol homeostasis on 
Nrf2. Recently, we developed mitochondria-
targeted reagents that can independently induce 
mitochondrial superoxide and hydrogen 
peroxide production (MitoPQ), or selectively 
disrupt mitochondrial thiol homeostasis 
(MitoCDNB). Using these reagents, here we 
have determined how enhanced generation of 
mitochondrial superoxide and hydrogen 
peroxide, or disruption of mitochondrial thiol 
homeostasis affect activation of the Nrf2 
system in cells, which was assessed by Nrf2 
protein level, nuclear translocation and 
expression of its target genes. We found that 
selective disruption of the mitochondrial 
glutathione pool and inhibition of its 
thioredoxin system by MitoCDNB led to Nrf2 
activation, while using MitoPQ to enhance 
production of mitochondrial superoxide and 
hydrogen peroxide alone did not. We further 
showed that Nrf2 activation by MitoCDNB 
requires cysteine sensors of Kelch-like ECH-
associated protein 1 (Keap1). These findings 
provide important information on how 
disruption to mitochondrial redox homeostasis 
is sensed in the cytoplasm and signaled to the 
nucleus.  
 
 
INTRODUCTION 
 
Oxidative stress and damage are involved in the 
development and progression of many diseases 
(1, 2). Cells are equipped with elaborate 
defense systems that allow them to maintain 
homeostasis in the face of physiological stress. 
The transcription factor Nrf2 plays a central 
role in the cytoprotective response to oxidative 
stress and damage (3, 4). In unstressed 
conditions, Nrf2 protein levels are maintained 
relatively low, which is due to its constitutive 
ubiquitination mediated by Keap1 (Kelch-like 
ECH-associated protein 1), an adaptor 
component of a Cul3 (Cullin 3) – based 
ubiquitin E3 ligase complex, which targets 
Nrf2 for proteasomal degradation (5, 6). Upon 
exposure to oxidants and/or electrophiles such 
as sulforaphane (SFN), specific cysteine 
sensors in Keap1 are modified, although the 
details of the specific reactions are not clear (7-
9). This inhibits the ubiquitination of Nrf2, 
which in turn leads to the stabilization and 
accumulation of Nrf2 (10). Nrf2 then 
translocates to the nucleus where it acts as a 
transcription factor, binding to the antioxidant 
response elements (ARE) in the promotor 
regions of Nrf2-target genes, upregulating the 
expression of a series of antioxidant genes (11, 
12).  
 
In addition to its role in overall cellular redox 
homeostasis, Nrf2 is also critical for the 
maintenance of mitochondrial antioxidant 
defenses and redox homeostasis (13). This is of 
particular importance because mitochondria are 
a major source of hydrogen peroxide due to 
superoxide production from respiratory 
complexes (14, 15). Within the mitochondrial 
matrix, this superoxide is rapidly converted by 
Mn superoxide dismutase (MnSOD) to 
hydrogen peroxide, which can both contribute 
to oxidative damage in a range of pathologies, 
but also acts as a signaling molecule that 
transduces redox signals through modifying the 
activity of redox-sensitive proteins (16-18). 
There are many mitochondrial thiol redox 
systems that are independent from those in the 
cytosol (19-21) and include the organelle’s 
glutathione (GSH) and thioredoxin (TRX) 
systems, both of which are critical for cell 
viability and function (22-24). Mitochondrial 
GSH is made in the cytosol and then 
transported from the cytosol into the 
mitochondrial matrix where it is maintained in 
a reduced state by glutathione reductase (GR) 
(24). GSH is used by glutathione peroxidases 
(GPX) 1 and 4, glutathione-S-transferases 
(GSTs) and glutaredoxin-2 to protect against 
ROS, electrophiles, xenobiotics and protein 
thiol oxidation (24). The mitochondrial TRX 
system consists of TRX2 and thioredoxin 
reductase 2 (TRXR2), which maintains TRX2 
in a reduced state by using mitochondrial 
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NADPH as a substrate (25, 26). TRX2 
maintains the activities of the peroxidase PRX3 
and of methionine sulfoxide reductases, while 
also directly reducing protein disulfides (27).  
 
Nrf2 activity enhances the expression of 
antioxidant systems (28, 29), including 
glutathione synthesis (30), GPXs (31), GR (32), 
PRX3 (33-35) and TRXR2 (33, 34). Nrf2 
activity also affects mitochondrial biogenesis 
by influencing expression of critical 
transcription factors, such as Peroxisome 
Proliferator Activated Receptor Gamma 
(PPARG) (37). These responses enable 
mitochondria to adapt to elevated oxidative 
stress and damage; consequently, Nrf2 
deficiency leads to mitochondrial damage (36). 
Therefore, it is widely assumed that Nrf2 is 
upregulated in response to mitochondrial 
oxidative stress and damage (28). However, the 
mechanistic details by which mitochondrial 
oxidative stress and damage activate Nrf2 are 
still unclear. Possibilities include that elevated 
mitochondrial superoxide production generates 
hydrogen peroxide that goes from the 
mitochondria to the cytosol to activate Nrf2 
directly or indirectly. Alternatively, the redox 
changes within the mitochondria may lead to 
secondary signals to the cytosol that then 
activate Nrf2. Finally, there are also 
suggestions that mitochondrial dysfunction 
may activate Nrf2 through formation of a 
complex with Keap1 and the mitochondrial 
outer membrane serine/threonine protein 
phosphatase, Phosphoglycerate Mutase Family 
Member 5 (PGAM5) (28, 38, 39). This Nrf2-
Keap1-PGAM5 complex has been proposed as 
an effector for ROS-induced necrosis and as an 
activator of mitochondrial fragmentation 
mediated through dephosphorylation of 
Dynamin Related Protein 1 (DRP1) (40). 
However, whether the role of Nrf2 bound to the 
mitochondrial outer membrane is distinct from 
that of the main cytosolic pool of Nrf2 is 
unclear.  
 
In exploring how mitochondrial oxidative 
stress and damage activate Nrf2 (28) it has not 
been possible to distinguish between the effects 
of superoxide and hydrogen peroxide 
generation and redox changes in mitochondria 
independently from those in the rest of the cell. 
Furthermore, many Nrf2 activators cause 
changes in both superoxide and hydrogen 
peroxide levels and in thiol homeostasis. 
However, these pathways interact closely and 
changes in thiol homeostasis can affect 
hydrogen peroxide levels, while conversely, 
increased levels of hydrogen peroxide can alter 
the thiol redox state via peroxidases (4, 12, 13). 
However, Nrf2 is regulated in different ways by 
these effectors, in part through the differential 
reactivity of particular thiols on Keap1 (41), 
suggesting that ROS such as hydrogen peroxide 
and thiol redox alterations affect Nrf2 
differently. Therefore, our challenge was to 
address the role in Nrf2 activation of 
mitochondrial redox changes independently of 
those from the cytosol while also distinguishing 
between the impact of mitochondrial 
superoxide and hydrogen peroxide production 
and that of thiol redox changes. To do this, we 
used two mitochondria-targeted redox active 
agents. To investigate thiol redox state, we used 
a mitochondria-targeted disrupter of thiol redox 
homeostasis MitoCDNB, a 1-chloro-2,4-
dinitrobenzene (CDNB) derivative that is 
selectively taken up by mitochondria within 
cells where it selectively depletes 
mitochondrial GSH largely, but not solely, by 
acting as a substrate for mitochondrial GSTs 
while also inhibiting the mitochondrial Trx 
system by inhibiting thioredoxin reductases 
(Fig. 1A) (45). In addition, we used MitoPQ, a 
mitochondria-targeted redox cycler, which is 
selectively taken up by mitochondria where the 
Paraquat moiety reacts with the complex I 
flavin to selectively increase superoxide 
production by redox cycling, and thus increase 
hydrogen peroxide within the mitochondrial 
matrix (Fig. 1B) (42-44). Our hypothesis was 
that inducing mitochondrial dysfunction 
through these two independent chemical 
biology approaches, would provide insights 
into the redox signaling mechanisms that 
underly activation of Nrf2 by mitochondrial 
oxidative stress and damage (Fig. 1). We found 
that disruption of the mitochondrial thiol 
homeostasis with MitoCDNB activated Nrf2, 
while enhancing mitochondrial superoxide 
production with MitoPQ did not. In addition, 
Nrf2 activation by MitoCDNB was greatly 
diminished by the thiol N-acetyl cysteine, and 
in cells expressing mutant Keap1 that lacked 
particular sensor cysteine residues. These 
results indicate that elevated mitochondrial 
superoxide generation alone does not activate 
Nrf2, but provide confirmation of direct 
signaling to the cytosol as a stress response to 
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disrupted mitochondrial thiol redox 
homeostasis.  
  
 
 
 
 
 
 
RESULTS AND DISCUSSION 
 
Selective disruption of mitochondrial thiol 
homeostasis activates Nrf2 
 
We first assessed if selective disruption of 
mitochondrial thiol redox homeostasis 
activated Nrf2. To do this we used the 
mitochondria-targeted thiol reagent 
MitoCDNB, which we had previously shown 
selectively depletes GSH and inhibits TrxR2 
within mitochondria, without directly affecting 
their cytosolic counterparts (45). Under control 
conditions, the Nrf2 protein is present at low 
levels and is only detectable in the cytosol of 
C2C12 mouse myoblasts (Fig. 2A). Treatment 
with H2O2 as a positive control (100 µM, 30 
min) increased the protein levels of Nrf2 within 
the cell ~2-fold (Fig. 2A) and caused its 
redistribution to the nucleus, as assessed by 
immunocytochemistry (Fig. 2B), as did the 
positive control SFN (Fig. S1). Similarly, 
MitoCDNB (10 µM, 4 h), increased Nrf2 
protein levels ~2-fold (Fig. 2A) and led to its 
translocation to the nucleus, as assessed by 
immunocytochemistry (Fig. 2B) and by sub-
cellular fractionation (Fig. 2C), with nearly 90 
% of cells having a clear nuclear distribution of 
Nrf2 upon MitoCDNB treatment (Fig. 2B). To 
determine whether this effect of MitoCDNB 
was due to its reaction with mitochondrial 
thiols, or by a non-specific disruption of 
mitochondria by accumulation of the 
triphenylphosphonium (TPP) targeting group, 
we synthesized a MitoCDNB control 
compound (Fig. S2). The control compound is 
structurally very similar to MitoCDNB and is 
accumulated by mitochondria in response to the 
membrane potential, but lacks thiol reactivity 
(Fig. S2, A-C). This control compound had no 
effect on Nrf2 protein levels or nuclear 
translocation (Fig. 2, A-D). Thus, the activation 
of Nrf2 by MitoCDNB is dependent on its thiol 
reactivity and not a non-specific interaction of 
the mitochondria-targeting moiety.  
 
To determine whether the nuclear accumulation 
of Nrf2 by MitoCDNB activates transcription 
of Nrf2-dependent genes, we assessed the 
levels of proteins known to be under Nrf2 
control via the ARE. Immunoblotting showed 
that MitoCDNB, but not its corresponding 
control compound, led to a time-dependent 
increase in the levels of the Nrf2 downstream 
targets glutamate-cysteine ligase catalytic 
subunit (GCLC), glutathione synthetase (GSS), 
and heme oxygenase-1 (HO-1). HO-1 was 
increased at 8- and 12 h post-exposure, while 
GCLC and GSS levels increased later, at 12 h 
(Fig. 3, A and B). To further confirm Nrf2 
activation, we used the quantitative 
NAD(P)H:quinone oxidoreductase-1 (NQO1) 
inducer assay (46, 47). The activity of this 
NAD(P)H:quinone oxidoreductase enzyme, 
which is involved in detoxification pathways, is 
a particularly sensitive indication of Nrf2 
activation as transcription of its gene is 
primarily regulated by Nrf2, and thus NQO1 is 
widely-recognized as a classical Nrf2 target 
(48). The potency of MitoCDNB was defined 
as the Concentration required to Double (CD) 
the NQO1 enzyme specific activity. For this 
Hepa1c1c7 cells were incubated with 
MitoCDNB, or its control, for 24 h, and NQO1 
activity was assessed. MitoCDNB elicited a 
pronounced concentration-dependent NQO1 
induction with a CD value of 12.5 µM that 
facilitates comparison of its potency with other 
inducers (Fig. 3C), whereas the control 
compound had no effect. We conclude that the 
selective disruption of mitochondrial thiol 
homeostasis by MitoCDNB activates Nrf2.  
 
Selective generation of superoxide within 
mitochondria does not activate Nrf2  
 
It has been previously reported that increasing 
mitochondrial oxidative damage and/or stress 
activates the Nrf2 pathway (28). It was further 
suggested that mitochondrial oxidative damage 
and/or stress activated Nrf2 through kinase-
dependent mechanisms such as the macrophage 
stimulating (Mst)1 and Mst2 systems (49). 
However, it was unclear whether mitochondrial 
superoxide production alone could activate 
Nrf2 by generating hydrogen peroxide as a 
redox signal that was released from the 
organelle to the cytosol, or whether the putative 
redox signal was secondary to 
intramitochondrial alterations. Therefore, here 
we used the targeted redox cycler MitoPQ to 
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generate superoxide selectively within 
mitochondria (40), without directly affecting 
other mitochondrial processes, or the cytosolic 
redox environment of C2C12 cells (44). The 
effects of MitoPQ were compared with its 
control compound, which is taken up by 
mitochondria within cells but does not generate 
superoxide (43). C2C12 cells treated with 5 µM 
MitoPQ, a concentration that has been shown to 
robustly increase superoxide production within 
mitochondria, but not in the cytosol, in C2C12 
cells (42), as was confirmed here by showing 
that MitoPQ did not induce oxidative stress 
within the cytosol (Fig. S3A). MitoPQ did not 
cause an increase in Nrf2 protein levels (Fig. 
4A), nor was there any localization of Nrf2 to 
the nucleus assessed by cell subfractionation 
followed by immunoblotting (Fig. 4B), in 
contrast to the positive control SFN (Fig. S1), 
or by immunofluorescence microscopy (Fig. 4, 
C and D), compared with the positive control 
H2O2. Under these conditions, MitoPQ did not 
elicit any changes in NQO1 activity (Fig. 4E) 
nor in the expression of the Nrf2 targets, 
GCLC, GSS and HO-1 (Fig. 4F and Fig. S3B). 
Increasing MitoPQ concentrations 5- to 10-fold 
did not enhance cell levels of Nrf2 (Fig. S3C), 
indicating that the lack of effect on NRF2 was 
not due to insufficient MitoPQ. We conclude 
that under these conditions the selective 
production of superoxide and hydrogen 
peroxide within the mitochondrial matrix does 
not activate Nrf2.  
 
Both MitoCDNB and CDNB lead to Nrf2 
activation, with NAC reversing MitoCDNB-
mediated Nrf2 activation 
 
From the previous results, we observed that 
MitoCDNB, but not MitoPQ, led to Nrf2 
stabilization, nuclear localization and enhanced 
expression of its downstream targets. 
Previously (45) it has been shown that 
MitoCDNB disrupts mitochondrial thiol 
antioxidant defenses as well as depleting 
mitochondrial GSH, which can disrupt 
mitochondrial thiol redox homeostasis, 
while the cytosolic GSH levels remained 
unchanged. In contrast, CDNB primarily 
disrupts cytosolic thiol antioxidant 
defenses (45). CDNB itself (5 µM) does 
increase Nrf2 protein levels (Fig. 5A) as well as 
its translocation to the nucleus (Fig. 5B) in 
C2C12 cells. Hepa1c1c7 cells exposed to 
CDNB and MitoCDNB both increased NQO1 
activity (Fig. 5C). As MitoCDNB acts in part 
by depleting mitochondrial GSH levels, we 
next assessed the effect of N-acetyl-L-cysteine 
(NAC), a GSH precursor that also increases cell 
thiol levels and can thereby directly ameliorate 
cellular oxidative stress that impacts thiols (50), 
on Nrf2 activation by MitoCDNB. NAC (1 
mM) added 1 hour before, or simultaneously 
with, MitoCDNB (10 µM, 4 h) prevented the 
induction by MitoCDNB of Nrf2 nuclear 
localization (Fig. 5D). As expected, NAC did 
not have an influence on SFN induced Nrf2 
nuclear localization (Fig. S4A). The 
MitoCDNB-mediated induction of NQO1 was 
also diminished when cells were either pre-
treated (24 h) or co-treated with NAC (Fig. 5E). 
Treatment with NAC at concentrations up to 10 
mM had no effect on the activity of NQO1 (Fig. 
S4B). As NAC and MitoCDNB do not interact 
directly (Fig. S5A), this suggests that NAC 
prevents the MitoCDNB-mediated Nrf2 
activation by boosting thiol defences within the 
cell. This was confirmed by showing that NAC 
did prevent depletion of whole cell GSH by 
CDNB and MitoCDNB (Fig. S5B) and 
increased mitochondrial GSH even in the 
presence of MitoCDNB (Fig. S5C). To 
investigate further how MitoCDNB affected 
the cytosol, we used CellROX, which is a 
fluorescent probe that responds to a wide range 
of oxidative processes, enabling us to measure 
changes in whole cell oxidative stress, but did 
not observe an increase with MitoCDNB (Fig. 
5F).  
 
MitoCDNB activates Nrf2 via altering sensor 
thiols on Keap1  
 
The above analysis indicates that MitoCDNB, 
but not MitoPQ, generates signals that activate 
Nrf2. Under homeostatic conditions, Nrf2 is 
bound to Keap1 and targeted for ubiquitination 
and proteolysis by the proteasome. The 
canonical pathway for the activation of Nrf2 by 
oxidants or electrophiles is via the reaction of 
the activators with thiols on Keap1, with 
specific thiols likely having particular 
reactivity with different species. These 
reactions disrupt the substrate adaptor function 
of Keap1 and enable Nrf2 to escape 
ubiquitination, migrate to the nucleus and 
activate gene expression. To interrogate the 
involvement of Keap1 in the mechanism of 
Nrf2 activation by MitoCDNB, we used mouse 
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embryonic fibroblast (MEF) cells expressing 
two different Keap1 cysteine mutants, or their 
wild-type counterpart (41). Specifically, these 
mutants were Keap1C151S and Keap1C226S/C613S 
(Fig. 6A). Cys151 on Keap1 is the main sensor 
for SFN, HNE and NO, while Cys226 and 
Cys613 respond to H2O2 (Fig. 6A) (51). The 
MEF cells were incubated with MitoCDNB and 
NQO1 activity was measured 24 h later (Fig. 
6B). In wild-type cells, MitoCDNB induced 
NQO1 in a concentration-dependent manner, 
but this induction was diminished in MEF cells 
expressing either of the Keap1 mutants (Fig. 
6B). The NQO1 inducer potency of the classical 
Nrf2 activator SFN was also greatly reduced in 
the Keap1C151S mutant cells in comparison with 
their wild-type or Keap1C226S/C613S counterparts, 
in agreement with previous reports that Cys151 
is the main sensor for SFN (7, 52) (Fig. 6C). 
The use of Keap1 mutants confirms that 
MitoCDNB activates Nrf2 through multiple 
cysteine sensors in Keap1, and further suggests 
the involvement of both electrophiles and 
oxidants as potential mediators. 
 
 
CONCLUSIONS 
 
Nrf2 plays a central role in the cytoprotective 
response to oxidative stress and is critical for 
the maintenance of mitochondrial redox 
homeostasis (13, 28). However, how 
mitochondrial oxidative stress and damage 
generates the signals that leads to Nrf2 
activation in the cytosol is not understood. To 
address this, we used selective chemical 
biology approaches that enabled us to 
interrogate separately the effects of 
mitochondrial superoxide and hydrogen 
peroxide production and disruption of thiol 
redox homeostasis. We demonstrate that 
disrupting mitochondrial thiol redox 
homeostasis leads to Nrf2 activation, whereas 
enhanced mitochondrial superoxide production 
alone does not.  
 
MitoCDNB has been previously shown to 
selectively deplete the mitochondrial 
glutathione pool and inhibit TrxR2 in cells and 
in vivo (45). Our current results show that in 
C2C12 cells MitoCDNB increases the levels of 
Nrf2, which then translocates to the nucleus 
(Fig. 2), inducing the expression of Nrf2 
downstream targets such as HO-1, GCLC, GSS 
and NQO1 (Fig. 3). By contrast, MitoPQ, a 
mitochondria-targeted redox cycler does not 
activate Nrf2 (Fig. 4). MitoPQ generates 
superoxide selectively within mitochondria, 
which is in turn rapidly dismutated to H2O2 
(42). The latter is formed locally and does not 
diffuse out of mitochondria within cells, which 
provides an explanation for why we do not 
observe Nrf2 activation. Furthermore, although 
there have been studies suggesting a link 
between mitochondrial hydrogen peroxide 
production with Nrf2 activation (28), such link 
has not been demonstrated directly. Our 
experiments with MitoPQ indicate that 
elevating superoxide and hydrogen peroxide 
within mitochondria, in the absence of other 
changes, is not capable of generating a 
hydrogen peroxide signal from the 
mitochondria to the cytosol to activate Nrf2. 
However, it is important to note that in 
disrupting the thiol-based antioxidant defenses, 
and peroxidases within mitochondria that 
MitoCDNB may lead indirectly to an elevation 
of mitochondrial hydrogen peroxide levels in 
the presence of other sources of superoxide 
(45). Thus, it may be that elevated 
mitochondrial hydrogen peroxide production, 
in conjunction with disruption of matrix thiol 
redox homeostasis, could lead to a 
mitochondria-generated hydrogen peroxide 
signal reaching the cytosol.  
  
Our studies found that although CDNB is also 
an Nrf2 activator, as it increases the protein 
levels of Nrf2 and leads to its translocation to 
the nucleus (Fig. 5), but it is much more toxic 
than its mitochondria- targeted counterpart 
MitoCDNB. This difference most likely arises 
because CDNB in the cytosol can affect global 
GSH levels both within the cytosol, and also 
those within mitochondria, due to the import of 
GSH from the cytosol to the mitochondria. 
Indeed, several studies have shown that 
global GSH depletion leads to activation of 
Nrf2 (53). It is also possible that CDNB may 
directly react with cysteines in Keap1; CDNB 
is a GST substrate, and GST substrates are 
known Nrf2 activators (54). In addition, NAC 
is generally regarded as a GSH precursor and 
therefore leads to an increase in GSH levels 
(50), but also increases levels of H2S (55), 
which may also contribute to its effects on 
MitoCDNB interactions with Nrf2 (56, 57). In 
the present study, we showed that pre- or co-
treatment with NAC blocks the MitoCDNB-
mediated stabilization and nuclear translocation 
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of Nrf2, and transcription of its downstream 
targets (Fig. 5). Furthermore, as shown in Fig. 
3, Nrf2 activation through MitoCDNB 
increases transcription of enzymes involved in 
glutathione metabolism; GCLC and GSS. 
Hence, our study suggests that mitochondrial 
glutathione depletion is a signal for Nrf2 
activation. This notion is also strengthened, by 
the fact that MitoCDNB affects Nrf2 after 4 h, 
but not 1 h (Fig. 2), when the mitochondrial 
GSH depletion is well underway (45).  
 
Here we show that MitoCDNB activates Nrf2 
through a Keap1-dependent mechanism that 
involves both Cys151 as well as the 
Cys226/Cys613 sensors (Fig. 6). These 
residues of Keap1 have been shown to mediate 
Nrf2 activation by inducers such as SFN, HNE 
and H2O2 (41). At non-toxic concentrations, 
CDNB does not lead to any NQO1 induction in 
MEF cells expressing either WT or Keap1 
cysteine mutants (data not shown), which 
suggests the effect of MitoCDNB is unrelated 
to any of its (minimal) cytosolic activity (Fig. 5 
and 6). Our previous studies have shown that 
MitoCDNB leads to mitochondrial 
fragmentation (45), which suggests 
involvement of Drp1, and it is of interest that 
Nrf2 activation facilitates the proteasomal 
degradation of Drp1 (58). Additionally, 
PGAM5 has been shown to act as a signaling 
hub, which brings the Keap1-Nrf2 complex to 
the mitochondria by forming a tripartite Keap1-
PGAM5-Nrf2 complex (38, 39). Although 
MitoCDNB, has been shown to increase 
mitochondrial ROS (45), we did not see any 
increase in cellular oxidative stress (Fig. 5) or 
leakage of H2O2 from isolated mitochondria 
previously (45). However, this does not exclude 
the possibility of mitochondrial hydrogen 
peroxide acting on Keap1 in the close vicinity 
to the mitochondria.  
 
In summary, we have shown that the selective 
disruption of mitochondrial thiol metabolism 
generates signals that then move from the 
mitochondria to the cytosol to interact with 
Keap1 cysteines to activate the Nrf2 pathway. 
The nature of these signals and how they exit 
mitochondria to interact with thiols on Keap1 
will be explored in future studies.  
 
 
EXPERIMENTAL PROCEDURES 
 
Cell culture 
 
C2C12 (Mouse muscle myoblast; ECACC) and 
MEF (Mouse embryonic fibroblast; (41)) cells 
were maintained at subconfluency (< 80 %) at 
37 °C in a humidified atmosphere of 95 % air 
and 5 % CO2 in Dulbecco’s Modified Eagle’s 
Medium (DMEM; Gibco) with high glucose 
(4.5 g/l D-glucose), supplemented with 10 % 
(v/v) fetal bovine serum (FBS), 100 U/mL 
penicillin and 100 µg/ml streptomycin. 
Hepa1c1c7 cells (Murine hepatoma cells; 
ECACC) were grown at 37 °C in a humidified 
atmosphere of 95 % air and 5 % CO2 in α-
minimum essential medium (α-MEM) 
supplemented with 10 % (v/v) heat- and 
charcoal-inactivated FBS with no antibiotics.  
 
Cellular Fractionation 
 
Cells were grown up to 20 x 106 in 150 mm 
dishes (Thermo Fisher Scientific). After 
appropriate incubations, cells were detached 
using trypsin, pelleted (150 x g, 3 min, RT) and 
resuspended in 1 ml fractionation buffer (FB) 
(220 mM D-mannitol, 70 mM sucrose, 1 mM 
EDTA, 10 mM Hepes, pH 7.4, 4 °C). Cells 
were homogenized by being passed through a 
27-gauge needle 10 times and a sample was 
taken as a whole cell fraction. The homogenate 
was centrifuged (720 x g, 5 min, 4 °C), with the 
whole cell supernatant stored and the nuclear 
pellet was washed and passed through a 25-
gauge needle 10 times. The subsequent nuclear 
homogenate was centrifuged again (720 x g, 5 
min, 4 °C), with the supernatant discarded and 
the pellet containing nuclei was kept as the 
nuclear fraction. The above-mentioned whole 
cell supernatant containing mitochondria, 
membranes and cytoplasm was recentrifuged 
(800 x g, 10 min, 4 °C) and pellet discarded, 
with this step repeated 3 times at which point 
no pellet was observed. The resulting 
supernatant was subsequently centrifuged 
(9000 x g, 10 min, 4 °C), collecting the 
supernatant (S) and resuspending the 
mitochondrial pellet (P) in 1 ml of FB. The 
centrifugation step was repeated on the 
supernatant. The resuspended pellet (P) was 
centrifuged (9000 x g, 15 min, 4 °C), the 
supernatant was discarded, and the pellet was 
resuspended in 50 µl FB (crude mitochondrial 
fraction). The supernatant (S) underwent an 
ultracentrifugation step (109,000 x g, 1 h, 4 °C) 
and the resulting supernatant was collected as 
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the cytosolic fraction. The protein 
concentration of each fraction was measured 
with a BCA assay (Thermo Fisher Scientific).  
 
Microscopy 
 
C2C12 cells were plated at 15,000 cells/well in 
24-well plates containing glass coverslips. 
After 16 hours the compounds of interest were 
added. At the end of the incubation the media 
was removed, cells were washed twice in cold 
PBS (Gibco), treated with 4 % (w/v) 
paraformaldehyde for 15 mins at 37 °C 
followed by three 5 min washes with PBS. Cells 
were then permeabilized with 0.1% (v/v) Triton 
X-100 in PBS for 10 min at RT, washed with 
PBS (3 x 10 min), blocked with 10 % (w/v) 
BSA in PBS for 20 min at RT, and then 
incubated with primary antibody in 5 % (w/v) 
BSA in PBS for 2 h at RT. Primary antibody 
solution was removed, cells washed with PBS 
(3 x 10 min) and incubated with secondary 
antibodies in 5 % (w/v) BSA in PBS for 1 h at 
RT. This solution was then removed and cells 
were washed with PBS (3 x 10 min). Coverslips 
were then mounted onto slides using Dako 
Mounting Medium (5 µl/coverslip; Agilent) 
and analyzed using Zeiss LSM880 confocal 
system equipped with a Zeiss Plan-Achromat 
63x/1.4 NA oil immersion objective. Z-stacks 
were acquired at 0.5-µm steps.  
Representative images for each condition were 
taken from >30 cells. This process was repeated 
on three separate cell passages to ensure 
biological replication. Primary antibody was 
rabbit anti-Nrf2 (1:1000; Cell Signaling 
Technologies, number: 12721). Secondary 
antibody was AlexaFluor488 goat anti-rabbit 
(1:1000; Thermo Fisher Scientific, number: A-
11008). 
 
Flow Cytometry 
 
C2C12s were seeded at 0.5 × 106 cells per ml 
and treated as described previously. Thirty 
minutes before the end of the stimulation, 
CellROX (1 μM) was added directly into the 
cell culture medium. Cells were incubated in 
tinfoil at 37 °C for 30 min. Fifteen minutes 
before the end of CellROX incubation, SYTOX 
Red (1 µM) was added into the cell culture 
medium. Cells were washed with PBS, scraped 
in PBS (0.5 ml), and transferred to 
polypropylene FACS tubes. At least 10,000 
total events were acquired using a BD 
LSRFortessa cell analyzer (BD Biosciences). 
CellROX Green and SYTOX Red were excited 
by laser at 488 nm and 640 nm, and the data 
were collected at forward scatter (FSC), side 
scatter (SSC), 530/30 nm (CellROX) and 
660/20 (SYTOX) detector. The data were 
analyzed using FlowJo software (version 
10.4.2), with the cell debris, represented by 
forward and side scatter, gated out for analysis. 
Median fluorescence intensity (MFI) of the 
530/30 nm channel was measured as a measure 
of cellular oxidative stress. 
 
Western Blotting 
 
C2C12 cells were plated at 300,000 cells/well 
in 6 well plates (Thermo Fisher Scientific) and 
treated with test reagents after a day of growth. 
At the end of the incubation the media was 
removed, cells were washed twice in cold PBS 
(Gibco), before addition of 100 µl of RIPA 
buffer (Merck) supplemented with protease 
inhibitors (cOmplete protease inhibitor 
cocktail, Merck) and 15 min incubation on ice. 
The samples were centrifuged at 17,000 g for 
10 min at 4 °C and the supernatants collected 
for protein quantification using the BCA assay 
(Thermo Fisher Scientific) with bovine serum 
albumin (BSA) as a standard. Samples were 
mixed with 4X loading buffer (200 mM Tris-
Cl, pH (6.8), 8 % (w/v) SDS, 0.4 % (w/v) 
bromophenol blue, 40 % (v/v) glycerol), 400 
mM DTT as a reductant. Typically 10-40 µg of 
protein was loaded onto 12 % or 4 – 20% Tris-
Glycine SDS-PAGE gels (BioRad) and run at 
120 V for 1 h. Protein was transferred to PVDF 
membranes (Immobilon®-FL or BioRad 
Trans-Blot® Turbo™Mini) by wet transfer (in 
the presence of 25 mM Tris, 192 mM glycine, 
20% (v/v) methanol, pH (8.4)) or semi-dry 
transfer (BioRad Trans-Blot® Turbo™) before 
blocking for 1 h at RT with Odyssey blocking 
buffer (LICOR). Primary antibody incubation 
was completed in 4 % (v/v) Odyssey buffer in 
PBS + 0.1 % (v/v) Tween-20 (PBST) overnight 
at 4 °C. Membranes were then washed 3 x 15 
min in PBST, followed by secondary antibody 
incubation in 4 % Odyssey buffer in PBS for 1 
h at RT, washed 2 x 15 min in PBST and 1 x 15 
min in PBS. Membranes were then visualized 
using a LICOR Odyssey CLx system or 
enhanced chemiluminescence (Amersham ECL 
prime Western blotting reagent) and analyzed 
using ImageStudio Lite. Primary antibodies: 
rabbit anti-GAPDH (1:5000, Sigma, number: 
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G9545), rabbit anti-Nrf2 (1:1000, Cell 
Signalling Technologies, number: 12721), 
mouse anti-histone 4 (1:1000, Cell Signaling 
Technologies, number: 2935), mouse anti-
Tubulin (1:1000, Abcam, number: ab56676) 
rabbit anti-GCLC (1:1000, Abcam, number: 
ab190685), rabbit anti-GSS (1:1000, Abcam, 
number: ab133592) and mouse anti-HO-1 
(1:1000, Abcam, number: ab13248). Secondary 
antibodies were goat anti-rabbit IRDye800 
(1:10000, LICOR, number: 926-32211) and 
goat anti-mouse IRDye680 (1:10000, LICOR, 
number: 926-68070), or goat anti-rabbit IgG 
HRP conjugate (1:3000, Promega, number: 
W4011) and goat anti-mouse IgG HRP 
conjugate (1:3000, Promega, number: W4021). 
 
 
Glutathione measurement 
 
To determine the total glutathione pool (GSH + 
2 x GSSG) whole cells (1x 106-9 cells) or 
mitochondrial fractions (isolated with the 
hypotonic method as described (45)) were 
treated with 100 µL 5 % (w/v) sulfosalicylic 
acid with vortexing for 30 s, proteins 
precipitated by centrifugation (16000 x g for 10 
min) and the supernatant analyzed by the GSH 
recycling assay as described (59, 60). Data are 
expressed as glutathione equivalents (GSH + 2 
x GSSG) normalized to protein determined by 
the BCA assay. 
 
NQO1 assay 
 
Inducer potency was quantified by use of the 
NQO1 bioassay in Hepa1c1c7 mouse hepatoma 
cells (46,47). Cells (1 x 104 per well of a 96-
well plate) were grown for 24 h and exposed 
(n = 8) to serial dilutions of compounds for the 
time periods indicated in the figure legends. 
NQO1 enzyme activity was quantified in cell 
lysates using menadione as a substrate. Protein 
concentrations were determined in aliquots 
from the same cell lysates by the bicinchoninic 
acid (BCA) assay (Thermo Scientific). The CD 
value was used as a measure of inducer 
potency. The same assay was used to determine 
the NQO1 enzyme activity in MEF cells, but 
the starting number of cells was 2 x 104 per 
well. 
Mitochondrial Isolation 
 
For isolated mitochondria studies, livers were 
prepared from rats. In all 
cases mitochondria were isolated 
by homogenization using a Dounce 
homogenizer followed by differential 
centrifugation at 4 °C. Liver mitochondria were 
prepared in STE buffer (250 mM sucrose, 
10 mM Tris, 1 mM EGTA, pH 
7.4). Homogenates were pelleted by 
centrifugation at 3000 x g for 3 min. The 
supernatant was collected and centrifuged at 10 
000 x g for 10 min. Mitochondrial pellets were 
resuspended in 10 ml and re-centrifuged at 
10000 x g for 10 min prior to final re-
suspension in 5 ml per liver. In all cases protein 
concentration was measured using the 
bicinchoninic acid (BCA) assay with BSA as a 
standard.  
 
Mitochondrial Incubations 
 
Mitochondrial incubations were in KCl buffer 
(120 mM KCl, 10 mM HEPES, 1 mM EGTA, 
pH 7.2) at 37°C, 
with succinate (10 mM), rotenone (4 μg/ml), 
FCCP (0.5 μM) added as appropriate, unless 
stated otherwise. After incubations 
mitochondria were pelleted by centrifugation 
(7500 x g for 10 min) and pellets and 
supernatants analyzed as necessary. 
Supernatants were immediately snap frozen 
while pellets were extracted in 250 µl 
acetonitrile (ACN) + 0.1 % trifluoroacetic acid 
(TFA) before centrifugation (16,000 x g, 10 
min, 4 °C) and the resulting supernatant snap 
frozen. 
 
RP-HPLC 
 
Samples for RP-HPLC were prepared by 
diluting to 25 % (v/v) acetonitrile (ACN) 
containing 0.1 % trifluoroacetic acid (TFA), 
followed by centrifugation (16000 x g for 
10 min) and filtration of 
the supernatant through a syringe-driven 
0.22 μm polyvinylidene difluoride (PVDF) 
filter unit (Millex, Millipore). Samples were 
then loaded into a 2 mL sample loop and 
separated by RP-HPLC using a C18 column 
(Jupiter 300A, Phenomenex) attached to a 
Widepore C18 guard column (Phenomenex), 
all driven by a Gilson 321 pump. A flow rate of 
1 ml/min was used with a gradient of 0.1 % 
(v/v) TFA in water (Buffer A) and 0.1 % (v/v) 
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TFA in acetonitrile (Buffer B) at: (% B). 0-
2 min; 5 %, 2-17 min; 5-100 %, 17-19 min; 100 
%, 19-22 min; 100-5%. Absorbance was 
measured at 220 (TPP) and 340 (GSH 
adduct) nm using a UV-Visible detector 
(Gilson 151). 
 
Synthesis of MitoCDNB Control  
 
Diisopropylamine (598 µL, 3.34 mmol, 2.0 eq) 
was added to a stirred solution of 5-chloro-2,4-
dinitrotoluene (397 mg, 1.83 mmol, 1.1 eq) and 
(4-aminobutyl)triphenylphosphonium bromide 
(692 mg, 1.67 mmol, 1.0 eq) in dry acetonitrile 
(10 mL) at RT under argon. The solution was 
stirred overnight poured into 1 M hydrochloric 
acid and extracted into CH2Cl2 (30 mL). The 
organic layer was washed with 1 M 
hydrochloric acid (2 × 100 mL), dried over 
sodium sulfate and concentrated under vacuum. 
The residue was purified by column 
chromatography using a 12 g Agela cartridge 
eluting with CH2Cl2:MeOH (100:0 increasing 
to 90:10 over 10 column volumes) to give the 
chloride salt of MitoCDNB control as a yellow 
solid foam (638 mg, 69%) (Fig. S6). dH (400 
MHz: CDCl3): 1.74-1.84 (2H, m, PCH2CH2), 
2.08-2.15 (2H, m, NCH2CH2), 2.71 (3H, s, Me), 
3.80 (2H, m, NHCH2), 4.05-4.12 (2H, m, 
PCH2), 7.25 (1H, s, H-6), 7.64-7.69 (6H, m, 
ArH), 7.74-7.79 (3H, m, ArH), 7.86-7.91 (6H, 
m, ArH), 8.29 (1H, t, J = 5.1 Hz, NH), 8.97 (1H, 
s, H-3). dC (101 MHz: CDCl3): 19.83 (d, J = 3.9 
Hz, CH2), 22.27 (d, J = 50.6 Hz, CH2), 22.27 
(CH3), 29.07 (d, J = 17.1 Hz, CH2), 42.44 
(CH2), 117.83 (CH), 118.34 (d, J = 85.9 Hz, C), 
125.79 (CH), 128.59 (C), 130.60 (d, J = 12.6 
Hz, CH), 133.84 (d, J = 10.0 Hz, CH), 135.15 
(d, J = 3.0 Hz, CH), 137.06 (C), 143.81 (C), 
147.25 (C). dP (162 MHz: CDCl3): 24.66 (s). 
m/z (ESI): Found: 514.1881. C29H29O4N3P 
requires M+, 514.1890.  
 
Statistical Analysis 
 
Statistical comparison between two groups was 
carried out using GraphPad Prism 7 software 
using two-tailed, unpaired Student’s t-tests or 
one-way ANOVA with the appropriate 
correction for multiple comparisons. Number 
of biological replicates (n) and statistical values 
are stated in each figure legend. n = number of 
replicates. Individual significant p values are 
shown in the figures (statistical significance 
corresponds to p < 0.05).  
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FIGURE 1. Mode of action of MitoCDNB and MitoPQ. 
A, MitoCDNB is composed of a 1,5-dichloro-2,4-dinitrobenzene (CDNB) moiety and mitochondria-targeting 
triphenylphosphonium cation. The latter leads to its selective accumulation within the mitochondrial matrix, 
driven by the plasma and mitochondrial membrane potentials. Within the mitochondria the CDNB moiety acts as 
a GST substrate to deplete GSH, and it is also a TrxR2 inhibitor, leading to the disruption of mitochondrial thiol 
redox defense homeostasis. We hypothesize this could lead to Nrf2 activation and its nuclear localization. Its 
inactive control compound, MitoCDNB Ctrl accumulates in the mitochondrial matrix but does not lead to GSH 
depletion or TrxR2 inhibition. B, MitoPQ is composed of a redox cycling paraquat moiety and a hydrophobic 
carbon chain linking it to a mitochondria-targeting triphenylphosphonium cation. MitoPQ is accumulated by 
mitochondria driven by the plasma and mitochondrial membrane potentials. Within the matrix, MitoPQ is reduced 
to a radical monocation by one-electron reduction at the flavin site of complex I, which subsequently interacts 
rapidly with O2 to generate superoxide (O2•-). We hypothesize the ability of mitochondrial specific O2•- production 
to activate the Keap1/Nrf2 pathway and lead to Nrf2 nuclear localization. The inactive control compound, MitoPQ 
Ctrl selectively accumulates in the matrix, but does not act as a redox cycler, and therefore is unable to produce 
O2•-.  
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FIGURE 2. Nrf2 protein levels and subcellular localization upon exposure to MitoCDNB. 
A, western blotting of Nrf2 protein levels. C2C12 cells were incubated with Vehicle (0.1% ethanol; Veh), H2O2 
(100 µM for 30 min), MitoCDNB (10 µM for 1 and 4 h) or MitoCDNB Ctrl (10 µM for 1 and 4 h). Protein levels 
were assessed by western blotting for Nrf2 (top) and GAPDH (bottom) in whole cell lysates and band intensities 
quantified (right). B, 3D maximum projection images showing fluorescence obtained with C2C12 cells with DAPI 
nuclear staining (first row), immunocytochemistry for Nrf2 (second row) and composite merge of the two 
fluorescent channels (third row) after treatment of 100 µM H2O2 for 30 min or 10 µM MitoCDNB for 4 h and 
MitoCDNB Ctrl. Scale bars: 20 µm. Nuclear distribution (right) is presented as mean % of all cells ± SD. Data 
are from 3 independent experiments; 30 cells were counted for each condition. C, C2C12 cells were incubated for 
4 h with 10 µM of either MitoCDNB Ctrl or MitoCDNB and fractionated into cytosolic and nuclear fractions. 
Protein levels were assessed by western blotting for Nrf2 (top), alpha-Tubulin (middle) and Histone-4 (bottom). 
All data are mean ± SD. Blots are representative of three independent experiments. P values were calculated using 
one-way ANOVA (Tukey’s post hoc correction for multiple comparison) or two-tailed, unpaired Student’s T-test. 
Individual significant p values are shown. 
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FIGURE 3. MitoCDNB induces Nrf2 downstream targets. 
A, induction of Nrf2 downstream targets (GCLC, GSS, HO-1) after treatment with 10 µM MitoCDNB and 
MitoCDNB Ctrl for 8, 12 or 24 h. Protein levels were assessed by western blotting for GCLC, GSS, HO-1 and 
GAPDH. B, relative fold of induction was obtained as compared to the untreated/MitoCDNB Ctrl and GAPDH 
western blots. Data are from 3 independent experiments. All data are mean ± SD. Blots are representative of three 
independent experiments. P values were calculated using one-way ANOVA (Tukey’s post hoc correction for 
multiple comparisons) or two-tailed, unpaired Student’s T-test. Individual significant p values are shown. C, 
NQO1 activity in mouse Hepa1c1c7 cells treated with MitoCDNB or MitoCDNB Ctrl for 48 h (n = 8). Mean 
values are shown. 
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FIGURE 4. MitoPQ effect on Nrf2 protein levels, its sub-cellular localization and downstream 
targets. 
A, western blotting of Nrf2 protein levels. C2C12 cells were incubated with Vehicle (0.1% ethanol; Veh), H2O2 
(100 µM for 30 min), MitoPQ (5 µM for 1 and 4 h), MitoPQ Ctrl (5 µM for 1 and 4 h). Lysates were then assessed 
by immunoblotting for Nrf2 (top) and GAPDH (bottom). B, C2C12 cells were incubated for 4 h with 5 µM of 
either MitoPQ Ctrl or MitoPQ and fractionated into cytosolic and nuclear fractions. Protein levels were assessed 
by western blotting for Nrf2 (top), alpha-Tubulin (middle) and Histone-4 (bottom). C, 3D maximum projection 
images showing fluorescence obtained with C2C12 cells with DAPI nuclear staining (first column), 
immunocytochemistry for Nrf2 (second column) and composite merge of the two fluorescent channels (third 
column). C2C12 cells were incubated with Vehicle (0.1% ethanol), MitoPQ Ctrl (5 µM) and MitoPQ (5 µM) for 
4 h; 100 µM H2O2 for 30 min (same positive control as in Fig. 2B). Scale bars: 20 µm. D, Quantification of 
nuclear distribution of Nrf2 in C2C12s after incubation with vehicle, 100 µM H2O2, 5 µM MitoPQ and MitoPQ 
Ctrl. Nuclear distribution is presented as mean % of all cells ± SD. Data are from 3 independent experiments, 30 
cells were counted for each condition. E, NQO1 activity in mouse Hepa1c1c7 cells treated with SFN (positive 
control), MitoPQ, MitoPQ Ctrl for 48 h (n = 8). Mean values are shown. F, induction of Nrf2 downstream targets 
(GCLC, GSS, HO-1) after treatment with 5 µM MitoPQ and MitoPQ Ctrl for 8,12, 24 h. Protein levels were 
assessed by western blotting for GCLC, GSS, HO-1 and GAPDH. Relative fold of induction was obtained as 
compared to the untreated/MitoPQ Ctrl and GAPDH. All data are mean ± SD. Blots are representative of three 
independent experiments. P values were calculated using one-way ANOVA (Tukey’s post hoc correction for 
multiple comparisons) or two-tailed, unpaired Student’s T-test. Individual significant p values are shown. 
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FIGURE 5. MitoCDNB and CDNB comparison. N-Acetyl-cysteine diminishes MitoCDNB effect 
on the Nrf2 pathway. 
A, western blotting of Nrf2 protein levels. C2C12 cells were incubated with Ctrl (0.1% ethanol), MitoCDNB (10, 
5 and 1 µM for 4 h) and CDNB (5 µM for 4 h). Protein levels were assessed by western blotting for Nrf2 (top) 
and GAPDH (bottom). B, 3D maximum projection images showing fluorescence obtained with C2C12 cells with 
DAPI nuclear staining (first row), immunocytochemistry for Nrf2 (second row). Nrf2 exhibits a cytosolic 
distribution, when C2C12 cells are incubated with Vehicle (0.1% ethanol) and a nuclear distribution when 
incubated with 10 µM MitoCDNB and 5 µM CDNB for 4 hours. Scale bar: 20 µm. C, NQO1 activity in Hepac1c7 
cells treated with MitoCDNB or CDNB for 24 h (n = 8). D, 3D maximum projection images showing fluorescence 
obtained with C2C12 cells with DAPI nuclear staining (first row), immunocytochemistry for Nrf2 (second row). 
C2C12 cells are incubated with NAC (1mM) and MitoCDNB Ctrl (10 µM) 4 h, whereas it exhibits a nuclear 
distribution with MitoCDNB (10 µM). After pre-treatment or co-treatment with 1 mM NAC a predominantly 
cytosolic distribution was observed. Scale bar: 20 µm. Quantification of nuclear distribution of Nrf2 in C2C12 
cells in conditions described above. Nuclear distribution is presented as mean % of all cells ± SD from 3 
independent experiments, 30 cells were counted for each condition. E, NQO1 activity in mouse Hepa1c1c7 cells 
treated with MitoCDNB (10 µM), NAC (1 mM pre-treatment) + MitoCDNB, or NAC (1 mM) + MitoCDNB (co-
treatment) for 24 h (n = 8). F, cellular oxidative stress levels were assessed with CellROX using flow cytometry 
in C2C12 cells incubated with vehicle (0.1% ethanol), TBHP (250 µM - positive control), 10 µM MitoCDNB or 
10 µM MitoCDNB Ctrl for 4 h. P values were calculated using one-way ANOVA (Tukey’s post hoc correction 
for multiple comparisons) or two-tailed, unpaired Student’s T-test. All data are mean ± SD. Blots are 
representative of three independent experiments. Individual significant p values are shown. 
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FIGURE 6. The inducer activity of MitoCDNB is diminished in MEF cells expressing Keap1 
cysteine mutants. 
A, a schematic representation of different classes of Nrf2 inducers acting on specific cysteines on Keap1, adapted 
from (41). B, NQO1 activity in Keap1WT, Keap1C151S and Keap1C226S/C613S MEF cells treated with MitoCDNB for 
24 h (n = 8). C, NQO1 activity in Keap1WT, Keap1C151S and Keap1C226S/C613S MEF cells treated with SFN for 24 h 
(n = 8). Mean values are shown.  
 
 
 
 
 
 
 
 
 
 
 
